BlackRock
AMPE

BlackRock’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

BlackRock’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,476
Closed -$281K – 5996
2022
Q3 		$281K Sell
15,476
-188
-1% -$6.58K ﹤0.01% 4888
2022
Q2 		$789K Sell
15,664
-30,990
-66% -$2.31M ﹤0.01% 4629
2022
Q1 		$6.58M Buy
46,654
+205
+0.4% +$29.9K ﹤0.01% 3805
2021
Q4 		$7.94M Buy
46,449
+5,495
+13% +$2.05M ﹤0.01% 3797
2021
Q3 		$20.4M Buy
40,954
+485
+1% +$225K ﹤0.01% 3261
2021
Q2 		$20.3M Buy
40,469
+28,622
+242% +$15.4M ﹤0.01% 3303
2021
Q1 		$6.01M Buy
11,847
+1,500
+14% +$774K ﹤0.01% 3854
2020
Q4 		$4.94M Buy
10,347
+5,075
+96% +$1.66M ﹤0.01% 3715
2020
Q3 		$1.51M Sell
5,272
-265
-5% -$65.7K ﹤0.01% 3980
2020
Q2 		$1.06M Buy
5,537
+1,118
+25% +$186K ﹤0.01% 4030
2020
Q1 		$551K Buy
4,419
+55
+1% +$9.96K ﹤0.01% 4034
2019
Q4 		$764K Buy
4,364
+13
+0.3% +$1.68K ﹤0.01% 4074
2019
Q3 		$654K Buy
4,351
+40
+0.9% +$5.33K ﹤0.01% 4102
2019
Q2 		$501K Sell
4,311
-15,794
-79% -$2.5M ﹤0.01% 4189
2019
Q1 		$3.39M Buy
20,105
+1,940
+11% +$332K ﹤0.01% 3544
2018
Q4 		$2.15M Buy
18,165
+210
+1% +$32.2K ﹤0.01% 3639
2018
Q3 		$2.74M Buy
17,955
+777
+5% +$325K ﹤0.01% 3669
2018
Q2 		$11.3M Buy
17,178
+13,071
+318% +$9.78M ﹤0.01% 3177
2018
Q1 		$4.19M Sell
4,107
-4
-0.1% -$3.35K ﹤0.01% 3473
2017
Q4 		$5.02M Buy
4,111
+23
+0.6% +$10.8K ﹤0.01% 3443
2017
Q3 		$749K Buy
4,088
+38
+0.9% +$6.02K ﹤0.01% 3988
2017
Q2 		$634K Sell
4,050
-6,938
-63% -$1.4M ﹤0.01% 3959
2017
Q1 		$2.64M Buy
10,988
+10,982
+183,033% +$2.95M ﹤0.01% 3580
2016
Q4 		$2K Hold
6
– – ﹤0.01% 3661
2016
Q3 		$1K Hold
6
– – ﹤0.01% 3670
2016
Q2 		$2K Buy
+6
New +$6.55K ﹤0.01% 3658
2015
Q2 		– Sell
-3
Closed -$7K – 3294
2015
Q1 		$7K Hold
3
– – ﹤0.01% 2940
2014
Q4 		$3K Hold
3
– – ﹤0.01% 3134
2014
Q3 		$3K Hold
3
– – ﹤0.01% 3158
2014
Q2 		$8K Sell
3
-1
-25% -$2.04K ﹤0.01% 2951
2014
Q1 		$8K Buy
4
+1
+33% +$2.37K ﹤0.01% 2877
2013
Q4 		$7K Hold
3
– – ﹤0.01% 2944
2013
Q3 		$7K Hold
3
– – ﹤0.01% 2875
2013
Q2 		$6K Buy
+3
New +$4.76K ﹤0.01% 2978

Other funds holding AMPE

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
WWM
Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
ARG
Advisory Resource Group Tulsa, Oklahoma $665M AUM 29.27% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

BlackRock's AMPE Position: Q4 2022 in Review

BlackRock sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2022, closing a stake of 15,476 shares — an estimated $281K sold.

BlackRock first reported a position in AMPE in Q2 2013 and held it in 34 quarters. The position peaked at $20.4M in Q3 2021. 32 funds tracked by Wall St. Rank hold AMPE as of Q4 2022.

  • BlackRock reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2022 after selling out during the quarter.
  • BlackRock sold 15,476 Ampio Pharmaceuticals Inc. shares in Q4 2022, an estimated $281K.
  • BlackRock first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 34 quarters.
  • BlackRock's Ampio Pharmaceuticals Inc. position peaked at $20.4M in Q3 2021.
  • 32 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2022.

Based on BlackRock's 13F filing for Q4 2022, filed 13 Feb 2023.